Cardiovascular and metabolic effects of the vasopeptidase inhibitor, omapatrilat in spontaneously hypertensive rats

被引：0
|
作者：
Ginoza, M [1 ]
Marques, A [1 ]
Cesaretti, M [1 ]
Zanella, M [1 ]
Ribeiro, A [1 ]
Kohlmann, O [1 ]
机构：
[1] Univ Fed Sao Paulo, Kidney & Hypertens Hosp, Div Nephrol, Sao Paulo, Brazil
来源：
JOURNAL OF HYPERTENSION | 2000年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 50 条
  • [11] Role for bradykinin on the cardiovascular effects of long-term vasopeptidase inhibition in spontaneously hypertensive rats (SHR)
    Marques, AG
    Cesaretti, MLR
    Ginoza, M
    Neves, CRS
    Kohlmann, NEB
    Tavares, A
    Zanella, MT
    Ribeiro, AB
    Kohlmann, O
    JOURNAL OF HYPERTENSION, 2004, 22 : S66 - S66
  • [12] Effects of the vasopeptidase inhibitor omapatrilat on cardiac endogenous kinins in rats with acute myocardial infarction
    Blais, C
    Lapointe, N
    Rouleau, JL
    Clément, R
    Gervais, N
    Geadah, D
    Adam, A
    PEPTIDES, 2001, 22 (06) : 953 - 962
  • [13] Effects of the vasopeptidase inhibitor omapatrilat on peri- and postrnyocardial infarction in Zucker lean rats
    Lapointe, N
    Parker, TG
    Tsoporis, JN
    Nguyen, QT
    Marcotte, F
    Adam, A
    Lou, I
    Rouleau, JL
    CANADIAN JOURNAL OF CARDIOLOGY, 2005, 21 (03) : 291 - 297
  • [14] Efficacy and safety of omapatrilat, a vasopeptidase inhibitor.
    Zusman, R
    Atlas, S
    Kochar, M
    Adler, E
    Levy, E
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 125A - 125A
  • [15] Effects of Vasopeptidase Inhibition on Renal Function and Tubuloglomerular Feedback in Spontaneously Hypertensive Rats
    Tao Wang
    Toshikazu Takabatake
    Hypertension Research, 2005, 28 : 611 - 618
  • [16] Effects of vasopeptidase inhibition on renal function and tubuloglomerular feedback in spontaneously hypertensive rats
    Wang, T
    Takabatake, T
    HYPERTENSION RESEARCH, 2005, 28 (07) : 611 - 618
  • [17] Cardiorenal protective effects of vasopeptidase inhibition with omapatrilat in hypertensive transgenic (mREN-2)27 rats
    Mifsud, SA
    Burrell, LM
    Kubota, E
    Jaworski, K
    Cooper, ME
    Wilkinson-Berka, JL
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2004, 26 (01) : 69 - 80
  • [18] Metabolic effects of telmisartan in spontaneously hypertensive rats
    Yong-Qi Li
    Hui Ji
    Yi-Hua Zhang
    Da-Yong Ding
    Xiao-Lei Ye
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2006, 373 : 264 - 270
  • [19] Metabolic effects of telmisartan in spontaneously hypertensive rats
    Li, Yong-Qi
    Ji, Hui
    Zhang, Yi-Hua
    Ding, Da-Yong
    Ye, Xiao-Lei
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 373 (04) : 264 - 270
  • [20] Effects of omapatrilat, a vasopeptidase inhibitor, on renal function and cardiac hypertrophy in rats with experimental heart failure.
    Abassi, Z
    Yahia, A
    Zeid, S
    Hayek, T
    Winaver, J
    Hoffman, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 514A - 514A
12345